These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25955465

  • 1. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
    Gifford G, Fay K, Jabbour A, Ma DD.
    Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
    [Abstract] [Full Text] [Related]

  • 2. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
    Lake W, Chang JE, Kennedy T, Morgan A, Salamat S, Başkaya MK.
    Neurosurgery; 2013 Jun; 72(6):960-70; discussion 970. PubMed ID: 23685504
    [Abstract] [Full Text] [Related]

  • 3. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 4. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 5. [Primary central nervous system post-transplant lymphoproliferative disorders].
    Honda M, Koga M, Kanda T.
    Brain Nerve; 2014 Aug; 66(8):947-54. PubMed ID: 25082316
    [Abstract] [Full Text] [Related]

  • 6. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 7. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 8. Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation.
    Osawa H, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.
    Int Surg; 2015 Feb 15; 100(2):358-64. PubMed ID: 25692442
    [Abstract] [Full Text] [Related]

  • 9. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov 15; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 15; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
    Wudhikarn K, Holman CJ, Linan M, Blaes AH, Dunitz JM, Hertz ME, Peterson BA.
    Clin Transplant; 2011 Jan 15; 25(5):705-13. PubMed ID: 21077949
    [Abstract] [Full Text] [Related]

  • 12. Late-Onset Central Nervous System Posttransplant Lymphoproliferative Disorder After Lung Transplantation:A Case Report.
    Ose N, Minami M, Funaki S, Kanou T, Fukui E, Morii E, Shintani Y.
    Transplant Proc; 2019 Nov 15; 51(9):3163-3166. PubMed ID: 31619339
    [Abstract] [Full Text] [Related]

  • 13. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, Caligiuri MA, Baiocchi RA.
    Transplantation; 2015 Jun 15; 99(6):1220-5. PubMed ID: 25427163
    [Abstract] [Full Text] [Related]

  • 14. Primary central nervous system posttransplantation lymphoproliferative disorder in an elderly liver transplant recipient.
    Dahiya S, Ooi WB, Ahluwalia MS, Asik A.
    J Am Geriatr Soc; 2012 Sep 15; 60(9):1777-8. PubMed ID: 22985151
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
    Peterson MR, Emery SC, Yung GL, Masliah E, Yi ES.
    Arch Pathol Lab Med; 2006 Feb 15; 130(2):176-80. PubMed ID: 16454557
    [Abstract] [Full Text] [Related]

  • 16. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Cavaliere R, Petroni G, Lopes MB, Schiff D, International Primary Central Nervous System Lymphoma Collaborative Group.
    Cancer; 2010 Feb 15; 116(4):863-70. PubMed ID: 20052713
    [Abstract] [Full Text] [Related]

  • 17. EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.
    Xu H, Rewerska J, Aardsma N, Slavin K, Valyi-Nagy T, Ni H.
    Folia Neuropathol; 2017 Feb 15; 55(3):221-226. PubMed ID: 28984115
    [Abstract] [Full Text] [Related]

  • 18. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R, Frost AE.
    J Heart Lung Transplant; 2005 Jun 15; 24(6):671-9. PubMed ID: 15949726
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 15; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 20. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.